Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-07-06 4:00 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Abingworth LLP | 10,544,399 13.2% | 5,640,831 (+115.04%) | View |
2020-06-11 5:00 pm Sale | 13D | SOLENO THERAPEUTICS INC NE SLNO | Vivo Ventures V LLC | 836,137 1.8% | -2,192,250 (-72.39%) | View |
2020-02-14 4:07 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | FEINBERG LARRY N | 5,700,047 12.3% | 1,639,987 (+40.39%) | View |
2020-02-14 12:24 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 4,277,923 9.6% | 4,277,923 (New Position) | View |
2020-02-13 09:58 am Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | 683 Capital Management LLC | 1,024,330 2.3% | -422,225 (-29.19%) | View |
2019-12-09 4:57 pm Sale | 13D | SOLENO THERAPEUTICS INC NE SLNO | Vivo Ventures V LLC | 3,028,387 6.65% | -1,473,851 (-32.74%) | View |
2019-12-03 5:23 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Vivo Ventures V LLC | 4,502,238 9.89% | 4,502,238 (New Position) | View |
2019-11-04 5:31 pm Sale | 13D | SOLENO THERAPEUTICS INC NE SLNO | BIOASIA MANGEMENT LLC | 4,952,195 11.3% | -364,958 (-6.86%) | View |